LanZhou Foci PharmaceuticalLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 1.9yrs |
Recent management updates
Recent updates
Here's Why LanZhou Foci PharmaceuticalLtd (SZSE:002644) Can Manage Its Debt Responsibly
Dec 13
Why LanZhou Foci PharmaceuticalLtd's (SZSE:002644) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 01These 4 Measures Indicate That LanZhou Foci PharmaceuticalLtd (SZSE:002644) Is Using Debt Reasonably Well
Aug 07LanZhou Foci PharmaceuticalLtd's (SZSE:002644) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 17LanZhou Foci Pharmaceutical Co.,Ltd.'s (SZSE:002644) 26% Price Boost Is Out Of Tune With Earnings
Mar 13LanZhou Foci Pharmaceutical Co.,Ltd.'s (SZSE:002644) 26% Price Boost Is Out Of Tune With Earnings
Mar 13CEO
LanZhou Foci PharmaceuticalLtd has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 3.3yrs | CN¥203.60k | no data | |
| Deputy General Manager | 9.1yrs | CN¥324.10k | no data | |
| Deputy General Manager | 9.1yrs | CN¥289.00k | no data | |
| Executive VP & Director | 1.7yrs | CN¥47.80k | no data | |
| Secretary of the Board | 3.3yrs | CN¥266.30k | no data | |
| Accounting Supervisor | no data | no data | no data |
Experienced Management: 002644's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP & Director | 1.6yrs | CN¥47.80k | no data | |
| Supervisor | 3.8yrs | no data | no data | |
| Chairman of the Supervisory Board | 11.8yrs | no data | no data | |
| Director | 3.3yrs | no data | no data | |
| Member of Supervisory Board | 6.2yrs | no data | no data | |
| Chairman | 1.9yrs | no data | no data | |
| Independent Director | 1.6yrs | CN¥27.00k | no data | |
| Independent Director | 1.6yrs | CN¥27.00k | no data | |
| Independent Director | 1.6yrs | CN¥27.00k | no data |
Experienced Board: 002644's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/17 09:47 |
| End of Day Share Price | 2026/03/17 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LanZhou Foci Pharmaceutical Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.